ClinicalTrials.Veeva

Menu

Effect of 10-day Overnight Hypoxia Treatment on Whole Body Insulin Sensitivity (SLEEP HIGH Study)

Pennington Biomedical Research Center logo

Pennington Biomedical Research Center

Status and phase

Completed
Early Phase 1

Conditions

Insulin Resistance

Treatments

Other: Hypoxia Exposure

Study type

Interventional

Funder types

Other

Identifiers

NCT01872533
PBRC 11009

Details and patient eligibility

About

The purpose of this study is to look at how a reduction in oxygen levels (hypoxia) influences insulin sensitivity and carbohydrate metabolism. It is expected that 10 nights of exposure to moderate hypoxia (~ 15% O2, similar to conditions at an altitude of ~7500 feet) will improve glucose metabolism.

Enrollment

9 patients

Sex

Male

Ages

20 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Aged 20-45 years
  • Male
  • Obese category (BMI > 30 kg/m2)
  • Healthy as assessed by a self-reported health questionnaire
  • Non-smokers
  • Weight stable over the past 3 months (<2kg fluctuation)

Exclusion criteria

  • Female
  • Diabetes
  • Sleep apnea
  • Hypertension
  • History of altitude sickness
  • Individuals taking any chronic medications
  • Individuals taking any stimulants
  • Individuals taking beta-blockers
  • Individuals with chronic alcohol consumption (>3 drinks per day) or drug abuse.
  • Individuals unable to abstain from caffeinated beverage or alcohol the days of study testing
  • Individuals with history disease or history of stroke

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

9 participants in 1 patient group

Hypoxia Exposure
Experimental group
Description:
There was only one study arm: All participants slept in moderate hypoxia (see description below).
Treatment:
Other: Hypoxia Exposure

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems